Global Oncology Precision Medicine Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Oncology Precision Medicine will have significant change from previous year. By the most conservative estimates of global Oncology Precision Medicine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Oncology Precision Medicine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Precision Medicine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Other Cancer
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Agilent Technologies
Almac
ANGLE plc
Asuragen
BGI Group
Bio-Rad Laboratories
BioMérieux
Bristol Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Precision Medicine Market Size 2016-2026
2.1.2 Oncology Precision Medicine Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Oncology Precision Medicine Segment by Type
2.2.1 Applied Sciences
2.2.2 Applied Sciences
2.2.3 Digital Health and Information Technology
2.2.4 Precision Therapeutics
2.3 Oncology Precision Medicine Market Size by Type
2.3.1 Global Oncology Precision Medicine Market Size CAGR by Type
2.3.2 Global Oncology Precision Medicine Market Size Market Share by Type (2016-2021)
2.4 Oncology Precision Medicine Segment by Application
2.4.1 Breast Cancer
2.4.2 Lung Cancer
2.4.3 Colorectal Cancer
2.4.4 Prostate Cancer
2.4.5 Cervical Cancer
2.4.6 Other Cancer
2.5 Oncology Precision Medicine Market Size by Application
2.5.1 Global Oncology Precision Medicine Market Size CAGR by Application
2.5.2 Global Oncology Precision Medicine Market Size Market Share by Application (2016-2021)
3 Oncology Precision Medicine Market Size by Players
3.1 Oncology Precision Medicine Market Size Market Share by Players
3.1.1 Global Oncology Precision Medicine Revenue by Players (2019-2021E)
3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2019-2021E)
3.2 Global Oncology Precision Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oncology Precision Medicine by Regions
4.1 Oncology Precision Medicine Market Size by Regions (2016-2021)
4.2 Americas Oncology Precision Medicine Market Size Growth (2016-2021)
4.3 APAC Oncology Precision Medicine Market Size Growth (2016-2021)
4.4 Europe Oncology Precision Medicine Market Size Growth (2016-2021)
4.5 Middle East & Africa Oncology Precision Medicine Market Size Growth (2016-2021)
5 Americas
5.1 Americas Oncology Precision Medicine Market Size by Country (2016-2021)
5.2 Americas Oncology Precision Medicine Market Size by Type (2016-2021)
5.3 Americas Oncology Precision Medicine Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Precision Medicine Market Size by Region (2016-2021)
6.2 APAC Oncology Precision Medicine Market Size by Type (2016-2021)
6.3 APAC Oncology Precision Medicine Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oncology Precision Medicine by Country (2016-2021)
7.2 Europe Oncology Precision Medicine Market Size by Type (2016-2021)
7.3 Europe Oncology Precision Medicine Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncology Precision Medicine by Region (2016-2021)
8.2 Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2021)
8.3 Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Oncology Precision Medicine Market Forecast
10.1 Global Oncology Precision Medicine Forecast by Regions (2021-2026)
10.1.1 Global Oncology Precision Medicine Forecast by Regions (2021-2026)
10.1.2 Americas Oncology Precision Medicine Forecast
10.1.3 APAC Oncology Precision Medicine Forecast
10.1.4 Europe Oncology Precision Medicine Forecast
10.1.5 Middle East & Africa Oncology Precision Medicine Forecast
10.2 Americas Oncology Precision Medicine Forecast by Countries (2021-2026)
10.2.1 United States Oncology Precision Medicine Market Forecast
10.2.2 Canada Oncology Precision Medicine Market Forecast
10.2.3 Mexico Oncology Precision Medicine Market Forecast
10.2.4 Brazil Oncology Precision Medicine Market Forecast
10.3 APAC Oncology Precision Medicine Forecast by Region (2021-2026)
10.3.1 China Oncology Precision Medicine Market Forecast
10.3.2 Japan Oncology Precision Medicine Market Forecast
10.3.3 Korea Oncology Precision Medicine Market Forecast
10.3.4 Southeast Asia Oncology Precision Medicine Market Forecast
10.3.5 India Oncology Precision Medicine Market Forecast
10.3.6 Australia Oncology Precision Medicine Market Forecast
10.4 Europe Oncology Precision Medicine Forecast by Country (2021-2026)
10.4.1 Germany Oncology Precision Medicine Market Forecast
10.4.2 France Oncology Precision Medicine Market Forecast
10.4.3 UK Oncology Precision Medicine Market Forecast
10.4.4 Italy Oncology Precision Medicine Market Forecast
10.4.5 Russia Oncology Precision Medicine Market Forecast
10.5 Middle East & Africa Oncology Precision Medicine Forecast by Region (2021-2026)
10.5.1 Egypt Oncology Precision Medicine Market Forecast
10.5.2 South Africa Oncology Precision Medicine Market Forecast
10.5.3 Israel Oncology Precision Medicine Market Forecast
10.5.4 Turkey Oncology Precision Medicine Market Forecast
10.5.5 GCC Countries Oncology Precision Medicine Market Forecast
10.6 Global Oncology Precision Medicine Forecast by Type (2021-2026)
10.7 Global Oncology Precision Medicine Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Oncology Precision Medicine Product Offered
11.1.3 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Information
11.2.2 Agilent Technologies Oncology Precision Medicine Product Offered
11.2.3 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Agilent Technologies Main Business Overview
11.2.5 Agilent Technologies Latest Developments
11.3 Almac
11.3.1 Almac Company Information
11.3.2 Almac Oncology Precision Medicine Product Offered
11.3.3 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Almac Main Business Overview
11.3.5 Almac Latest Developments
11.4 ANGLE plc
11.4.1 ANGLE plc Company Information
11.4.2 ANGLE plc Oncology Precision Medicine Product Offered
11.4.3 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 ANGLE plc Main Business Overview
11.4.5 ANGLE plc Latest Developments
11.5 Asuragen
11.5.1 Asuragen Company Information
11.5.2 Asuragen Oncology Precision Medicine Product Offered
11.5.3 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Asuragen Main Business Overview
11.5.5 Asuragen Latest Developments
11.6 BGI Group
11.6.1 BGI Group Company Information
11.6.2 BGI Group Oncology Precision Medicine Product Offered
11.6.3 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 BGI Group Main Business Overview
11.6.5 BGI Group Latest Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Information
11.7.2 Bio-Rad Laboratories Oncology Precision Medicine Product Offered
11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Bio-Rad Laboratories Main Business Overview
11.7.5 Bio-Rad Laboratories Latest Developments
11.8 BioMérieux
11.8.1 BioMérieux Company Information
11.8.2 BioMérieux Oncology Precision Medicine Product Offered
11.8.3 BioMérieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 BioMérieux Main Business Overview
11.8.5 BioMérieux Latest Developments
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Information
11.9.2 Bristol Myers Squibb Oncology Precision Medicine Product Offered
11.9.3 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Bristol Myers Squibb Main Business Overview
11.9.5 Bristol Myers Squibb Latest Developments
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Information
11.10.2 Roche Holding AG Oncology Precision Medicine Product Offered
11.10.3 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Roche Holding AG Main Business Overview
11.10.5 Roche Holding AG Latest Developments
11. Gilead Sciences
11.11.1 Gilead Sciences Company Information
11.11.2 Gilead Sciences Oncology Precision Medicine Product Offered
11.11.3 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Gilead Sciences Main Business Overview
11.11.5 Gilead Sciences Latest Developments
11.12 Illumina
11.12.1 Illumina Company Information
11.12.2 Illumina Oncology Precision Medicine Product Offered
11.12.3 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Illumina Main Business Overview
11.12.5 Illumina Latest Developments
11.13 Konica Minolta
11.13.1 Konica Minolta Company Information
11.13.2 Konica Minolta Oncology Precision Medicine Product Offered
11.13.3 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Konica Minolta Main Business Overview
11.13.5 Konica Minolta Latest Developments
11.14 LabCorp
11.14.1 LabCorp Company Information
11.14.2 LabCorp Oncology Precision Medicine Product Offered
11.14.3 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 LabCorp Main Business Overview
11.14.5 LabCorp Latest Developments
11.15 MDxHealth
11.15.1 MDxHealth Company Information
11.15.2 MDxHealth Oncology Precision Medicine Product Offered
11.15.3 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 MDxHealth Main Business Overview
11.15.5 MDxHealth Latest Developments
11.16 Myriad Genetics
11.16.1 Myriad Genetics Company Information
11.16.2 Myriad Genetics Oncology Precision Medicine Product Offered
11.16.3 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Myriad Genetics Main Business Overview
11.16.5 Myriad Genetics Latest Developments
11.17 Novartis
11.17.1 Novartis Company Information
11.17.2 Novartis Oncology Precision Medicine Product Offered
11.17.3 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Novartis Main Business Overview
11.17.5 Novartis Latest Developments
11.18 OPKO Health
11.18.1 OPKO Health Company Information
11.18.2 OPKO Health Oncology Precision Medicine Product Offered
11.18.3 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 OPKO Health Main Business Overview
11.18.5 OPKO Health Latest Developments
11.19 Pacific Biosciences
11.19.1 Pacific Biosciences Company Information
11.19.2 Pacific Biosciences Oncology Precision Medicine Product Offered
11.19.3 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Pacific Biosciences Main Business Overview
11.19.5 Pacific Biosciences Latest Developments
11.20 Quest Diagnostics
11.20.1 Quest Diagnostics Company Information
11.20.2 Quest Diagnostics Oncology Precision Medicine Product Offered
11.20.3 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Quest Diagnostics Main Business Overview
11.20.5 Quest Diagnostics Latest Developments
11.21 Qiagen
11.21.1 Qiagen Company Information
11.21.2 Qiagen Oncology Precision Medicine Product Offered
11.21.3 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 Qiagen Main Business Overview
11.21.5 Qiagen Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Oncology Precision Medicine Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Applied Sciences
Table 3. Major Players of Precision Diagnostics
Table 4. Major Players of Digital Health and Information Technology
Table 5. Major Players of Precision Therapeutics
Table 6. Oncology Precision Medicine Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Oncology Precision Medicine Market Size Market Share by Type (2016-2021)
Table 9. Oncology Precision Medicine Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Oncology Precision Medicine Market Size Market Share by Application (2016-2021)
Table 12. Global Oncology Precision Medicine Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Oncology Precision Medicine Revenue Market Share by Players (2019-2021E)
Table 14. Oncology Precision Medicine Key Players Head office and Products Offered
Table 15. Oncology Precision Medicine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oncology Precision Medicine Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Oncology Precision Medicine Market Size Market Share by Regions 2016-2021
Table 20. Americas Oncology Precision Medicine Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Oncology Precision Medicine Market Size Market Share by Country (2016-2021)
Table 22. Americas Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Oncology Precision Medicine Market Size Market Share by Type (2016-2021)
Table 24. Americas Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Oncology Precision Medicine Market Size Market Share by Application (2016-2021)
Table 26. APAC Oncology Precision Medicine Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Oncology Precision Medicine Market Size Market Share by Region (2016-2021)
Table 28. APAC Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Oncology Precision Medicine Market Size Market Share by Type (2016-2021)
Table 30. APAC Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Oncology Precision Medicine Market Size Market Share by Application (2016-2021)
Table 32. Europe Oncology Precision Medicine Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Oncology Precision Medicine Market Size Market Share by Country (2016-2021)
Table 34. Europe Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Oncology Precision Medicine Market Size Market Share by Type (2016-2021)
Table 36. Europe Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Oncology Precision Medicine Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Oncology Precision Medicine Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Oncology Precision Medicine
Table 45. Key Application and Potential Industries of Oncology Precision Medicine
Table 46. Key Challenges of Oncology Precision Medicine
Table 47. Key Trends of Oncology Precision Medicine
Table 48. Global Oncology Precision Medicine Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Oncology Precision Medicine Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Oncology Precision Medicine Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Oncology Precision Medicine Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Oncology Precision Medicine Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Oncology Precision Medicine Market Size Market Share Forecast by Application (2021-2026)
Table 54. Abbott Laboratories Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 55. Abbott Laboratories Oncology Precision Medicine Product Offered
Table 56. Abbott Laboratories Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. Abbott Laboratories Main Business
Table 58. Abbott Laboratories Latest Developments
Table 59. Agilent Technologies Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 60. Agilent Technologies Oncology Precision Medicine Product Offered
Table 61. Agilent Technologies Main Business
Table 62. Agilent Technologies Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Agilent Technologies Latest Developments
Table 64. Almac Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 65. Almac Oncology Precision Medicine Product Offered
Table 66. Almac Main Business
Table 67. Almac Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Almac Latest Developments
Table 69. ANGLE plc Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 70. ANGLE plc Oncology Precision Medicine Product Offered
Table 71. ANGLE plc Main Business
Table 72. ANGLE plc Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. ANGLE plc Latest Developments
Table 74. Asuragen Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 75. Asuragen Oncology Precision Medicine Product Offered
Table 76. Asuragen Main Business
Table 77. Asuragen Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Asuragen Latest Developments
Table 79. BGI Group Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 80. BGI Group Oncology Precision Medicine Product Offered
Table 81. BGI Group Main Business
Table 82. BGI Group Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. BGI Group Latest Developments
Table 84. Bio-Rad Laboratories Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 85. Bio-Rad Laboratories Oncology Precision Medicine Product Offered
Table 86. Bio-Rad Laboratories Main Business
Table 87. Bio-Rad Laboratories Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Bio-Rad Laboratories Latest Developments
Table 89. BioMérieux Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 90. BioMérieux Oncology Precision Medicine Product Offered
Table 91. BioMérieux Main Business
Table 92. BioMérieux Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. BioMérieux Latest Developments
Table 94. Bristol Myers Squibb Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 95. Bristol Myers Squibb Oncology Precision Medicine Product Offered
Table 96. Bristol Myers Squibb Main Business
Table 97. Bristol Myers Squibb Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. Bristol Myers Squibb Latest Developments
Table 99. Roche Holding AG Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 100. Roche Holding AG Oncology Precision Medicine Product Offered
Table 101. Roche Holding AG Main Business
Table 102. Roche Holding AG Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. Roche Holding AG Latest Developments
Table 104. Gilead Sciences Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 105. Gilead Sciences Oncology Precision Medicine Product Offered
Table 106. Gilead Sciences Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Gilead Sciences Main Business
Table 108. Gilead Sciences Latest Developments
Table 109. Illumina Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 110. Illumina Oncology Precision Medicine Product Offered
Table 111. Illumina Main Business
Table 112. Illumina Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. Illumina Latest Developments
Table 114. Konica Minolta Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 115. Konica Minolta Oncology Precision Medicine Product Offered
Table 116. Konica Minolta Main Business
Table 117. Konica Minolta Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 118. Konica Minolta Latest Developments
Table 119. LabCorp Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 120. LabCorp Oncology Precision Medicine Product Offered
Table 121. LabCorp Main Business
Table 122. LabCorp Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 123. LabCorp Latest Developments
Table 124. MDxHealth Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 125. MDxHealth Oncology Precision Medicine Product Offered
Table 126. MDxHealth Main Business
Table 127. MDxHealth Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 128. MDxHealth Latest Developments
Table 129. Myriad Genetics Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 130. Myriad Genetics Oncology Precision Medicine Product Offered
Table 131. Myriad Genetics Main Business
Table 132. Myriad Genetics Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 133. Myriad Genetics Latest Developments
Table 134. Novartis Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 135. Novartis Oncology Precision Medicine Product Offered
Table 136. Novartis Main Business
Table 137. Novartis Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 138. Novartis Latest Developments
Table 139. OPKO Health Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 140. OPKO Health Oncology Precision Medicine Product Offered
Table 141. OPKO Health Main Business
Table 142. OPKO Health Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 143. OPKO Health Latest Developments
Table 144. Pacific Biosciences Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 145. Pacific Biosciences Oncology Precision Medicine Product Offered
Table 146. Pacific Biosciences Main Business
Table 147. Pacific Biosciences Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 148. Pacific Biosciences Latest Developments
Table 149. Quest Diagnostics Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 150. Quest Diagnostics Oncology Precision Medicine Product Offered
Table 151. Quest Diagnostics Main Business
Table 152. Quest Diagnostics Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 153. Quest Diagnostics Latest Developments
Table 154. Qiagen Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 155. Qiagen Oncology Precision Medicine Product Offered
Table 156. Qiagen Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 157. Qiagen Main Business
Table 158. Qiagen Latest Developments
List of Figures
Figure 1. Oncology Precision Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Precision Medicine Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Oncology Precision Medicine Market Size Market Share by Type in 2020
Figure 7. Oncology Precision Medicine in Breast Cancer
Figure 8. Global Oncology Precision Medicine Market: Breast Cancer (2016-2021) & ($ Millions)
Figure 9. Oncology Precision Medicine in Lung Cancer
Figure 10. Global Oncology Precision Medicine Market: Lung Cancer (2016-2021) & ($ Millions)
Figure 11. Oncology Precision Medicine in Colorectal Cancer
Figure 12. Global Oncology Precision Medicine Market: Colorectal Cancer (2016-2021) & ($ Millions)
Figure 13. Oncology Precision Medicine in Prostate Cancer
Figure 14. Global Oncology Precision Medicine Market: Prostate Cancer (2016-2021) & ($ Millions)
Figure 15. Oncology Precision Medicine in Cervical Cancer
Figure 16. Global Oncology Precision Medicine Market: Cervical Cancer (2016-2021) & ($ Millions)
Figure 17. Oncology Precision Medicine in Other Cancer
Figure 18. Global Oncology Precision Medicine Market: Other Cancer (2016-2021) & ($ Millions)
Figure 19. Global Oncology Precision Medicine Market Size Market Share by Application in 2020
Figure 20. Global Oncology Precision Medicine Revenue Market Share by Player in 2020
Figure 21. Global Oncology Precision Medicine Market Size Market Share by Regions (2016-2021)
Figure 22. Americas Oncology Precision Medicine Market Size 2016-2021 ($ Millions)
Figure 23. APAC Oncology Precision Medicine Market Size 2016-2021 ($ Millions)
Figure 24. Europe Oncology Precision Medicine Market Size 2016-2021 ($ Millions)
Figure 25. Middle East & Africa Oncology Precision Medicine Market Size 2016-2021 ($ Millions)
Figure 26. Americas Oncology Precision Medicine Market Size Market Share by Country in 2020
Figure 27. Americas Oncology Precision Medicine Market Size Market Share by Type in 2020
Figure 28. Americas Oncology Precision Medicine Market Size Market Share by Application in 2020
Figure 29. United States Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 30. Canada Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 31. Mexico Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 32. APAC Oncology Precision Medicine Market Size Market Share by Regions in 2020
Figure 33. APAC Oncology Precision Medicine Market Size Market Share by Type in 2020
Figure 34. APAC Oncology Precision Medicine Market Size Market Share by Application in 2020
Figure 35. China Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 36. Japan Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 37. Korea Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 38. Southeast Asia Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 39. India Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 40. Australia Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 41. Europe Oncology Precision Medicine Market Size Market Share by Country in 2020
Figure 42. Europe Oncology Precision Medicine Market Size Market Share by Type in 2020
Figure 43. Europe Oncology Precision Medicine Market Size Market Share by Application in 2020
Figure 44. Germany Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 45. France Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 46. UK Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 47. Italy Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 48. Russia Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 49. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Region in 2020
Figure 50. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Type in 2020
Figure 51. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Application in 2020
Figure 52. Egypt Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 53. South Africa Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 54. Israel Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 55. Turkey Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 56. GCC Country Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)
Figure 57. Americas Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 58. APAC Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 59. Europe Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 60. Middle East & Africa Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 61. United States Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 62. Canada Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 63. Mexico Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 64. Brazil Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 65. China Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 66. Japan Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 67. Korea Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 68. Southeast Asia Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 69. India Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 70. Australia Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 71. Germany Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 72. France Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 73. UK Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 74. Italy Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 75. Russia Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 76. Spain Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 77. Egypt Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 78. South Africa Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 79. Israel Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 80. Turkey Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Figure 81. GCC Country Oncology Precision Medicine Market Size 2021-2026 ($ Millions)
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets